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Background: Snakebites are considered a neglected tropical disease that affects thousands of people worldwide.
Although antivenom is the only treatment available, it is associated with several side effects. As an alternative,
plants have been extensively studied in order to obtain an alternative treatment. In folk medicine, Azima
tetracantha Lam. is usually used to treat snakebites. The present study aims to provide a scientific explanation for
the use of this plant against snakebite. The extracts of shade dried leaves of A. tetracantha were tested for in vitro
inhibitory activity on toxic venom enzymes like phosphomonoesterase, phosphodiesterase, acetylcholinesterase,
hyaluronidase etc. from Bungarus caeruleus and Vipera russelli venoms.
Results: The ethylacetate extract rendered a significant inhibitory effect on the phosphomonoesterase,
phosphodiesterase, phospholipase A2 and acetylcholinesterase enzymes.
Conclusions: The present study suggests that ethylacetate extract of A. tetracantha leaves possesses compounds that
inhibit the activity of toxic enzymes from Bungarus caeruleus and Vipera russelli venom. Further pharmacological and
in vivo studies would provide evidence that this substance may lead to a potential treatment against these venoms.
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Snakebite remains a major health concern throughout the
world especially in India, due to the high mortality rate in
the country. Worldwide, snake envenomation incidence ex-
ceeds 5 million affected people per year [1]. In Asia, an esti-
mated four million snakebites occur every year, of which
approximately 50% of the victims are envenomed, resulting
in 100,000 annual deaths [2]. In India alone about 35,000 to
50,000 deaths occur annually. The major families of snakes
in India are Elapidae, Viperidae and Hydrophidae. The most
common poisonous snakes in the country are cobra (Naja
naja), krait (Bungarus caeruleus), Russell’s viper (Daboia
russelli) and saw-scaled viper (Echis carinatus). The former
two belong to Elapidae and the latter two belong to Viperi-
dae [3]. The venoms of cobra and krait are neurotoxic, that
is, they affect the victim’s central nervous system and cause
heart failure. Their venom possesses several proteins,* Correspondence: sunilacr@yahoo.co.in
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article, unless otherwise stated.including cardiotoxins, neurotoxins and phospholipase A2,
that are responsible for their toxicity. The venoms of Rus-
sell’s viper and saw-scaled viper are histotoxic and
hemorrhagic, therefore they provoke hemorrhagic manifes-
tations that include epistaxis and cardiac manifestations
such as myocarditis and cardiac failure [4].
Presently, antivenom immunotherapy is the only treat-
ment available against snake envenomation. The side ef-
fects of antivenom include anaphylactic shock, pyrogen
reaction and serum sickness. These symptoms are possibly
outcomes of the action of non-immunoglobulin proteins
present in higher concentrations in antivenom [5]. In this
perspective, several attempts have been made to develop
snake venom antagonists from plants. In folk medicine,
plant drug recipes are passed on to generations by oral
tradition and are used as antidotes [6]. Considering the
limitations of antivenom, investigations on plants are based
on the fact that some of their extracts are rich in bioactive
compounds with promising antivenom effects [7,8].
Hemidesmus indicus root extract and methanolic leaf ex-
tract of Azadirachta indica have been proved to neutralizetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Janardhan et al. Journal of Venomous Animals and Toxins including Tropical Diseases 2014, 20:12 Page 2 of 8
http://www.jvat.org/content/20/1/12phospholipase A2 activity induced by Russell’s viper venom
[9,10]. Mimosa pudica has shown antihyaluronidase activ-
ity against Naja naja, Vipera russelli and Echis carinatus
venoms [11]. Echis carinatus enzymatic effects have been
inhibited by the extracts of Andrographis paniculata and
Aristolochia indica. Enzymatic and pharmacological activ-
ities of phospholipase A2 induced by Vipera russelli venom
have been inhibited by aristolochic acid from Aristolochia
radix [12,13].
In vitro tests with polyphenols from Areca catechu L.
and Quercus infectoria Oliv. showed inhibition of phospho-
lipase A2, proteases, hyaluronidase and L-amino acid
oxidase of Naja naja kaouthia and Calloselasma rhodos-
toma venoms [14]. In addition, Tamarindus indica has
shown potent venom neutralizing properties [15].
Azima tetracantha Lam. belongs to the Salvodoraceae
family, it is known as Kundali in Ayurvedic medicine and
also called uppimullu in kannada [16,17]. Antidiarrheal
activity has been reported in this plant and antimicrobial
activity in its fruits [18,19]. Moreover, there are reports
that the juice of its leaves is efficient against toothache
and earache [20]. In Indian tribes, leaf paste of A.
tetracantha is used to treat snakebites [17]. The
presence of dimeric piperdine alkaloids azimine, aza-
carpaine, carpaine, triterpenoids, isorhamnetin 3-
rutinoside, neoascorbinogen and glucosinolates and
novel fatty acids have been reported as some of the
phytochemicals present in the plant [21-25]. The
present study investigates the neutralizing activity of
A. tetracantha plant extracts on krait and Russell’s
viper venom toxic enzymes by in vitro methods.
Methods
Venom
The lyophilized venoms of Bungarus caeruleus and
Vipera russelli were obtained from Irula Snake Catcher’s
Cooperative Society, Kancheepuram, Chennai. Snake
venom (5 mg/mL) was dissolved in physiological saline
and centrifuged at 2000 g for ten minutes. The super-
natant was used for further analysis and stored at 4°C.
The protein concentration was estimated according to
the method of Lowry et al. [26].
5′ Adenosine mono phosphate (5′ AMP), disodium-p-
nitrophenol phosphate, L-leucine, diansidine hydrochlor-
ide, horseradish peroxidase, 5,5′-dithiobis-(2-nitrobenzoic
acid) (DTNB), acetylthiocholine iodide, hyaluronic acid,
cetyltrimethylammonium bromide, lecithin were pur-
chased from Himedia Laboratories (India) and casein
from Sigma Aldrich Laboratories (USA). All the other re-
agents were of analytical grade.
Plants and extraction
Fresh leaves of A. tetracantha were collected in September
in Kurubarahatty village, Chitradurga district, Karnataka,India. The plant specimens were identified and authenti-
cated by the National Ayurveda Dietetics Research Institute,
Bangalore, Karnataka (Drug Authentication/SMPU/
NADRI/BNG/2013-2014/765). The leaves were thor-
oughly washed in order to remove adhering dust, shade
dried and ground into powder for further use.
Powdered material was prepared in soxhlet apparatus
using petroleum ether (60-80°C), hexane, chloroform,
ethyl acetate, methanol and water. The extraction proced-
ure was carried out until the solvent becomes colorless in
the soxhlet loop. The extracts were dried using rotary vac-
cum evaporator and the residue was expressed in terms of
dry weight, which was used for further analysis.
About 50 g of leaf powder was soaked in 150 mL of
ethanol overnight and filtered. The residue left after fil-
tration was suspended in the same amount of ethanol
and left for 48 hours. The two filtrates were mixed, dried
using rotatory vacuum evaporator and the residue was
stored for further use.
Qualitative analysis of extracts
Phytochemical analysis of the extracts was performed to
detect the presence of constituents such as alkaloids, ter-
penoids, flavonoids, phenols, saponins, carbohydrates and
other metabolites [27,28].
Thin layer chromatography of extracts
The extracts were examined by thin layer chromatography
(TLC) on analytical plates over silica gel (TLC grade,
Merck, India). The different solvent systems used for sep-
aration were petroleum ether and ethylacetate, hexane
and ethylacetate in three different ratios (9:1, 8:2, 7:3);
methanol, water, formic acid in the ratio 18:9:1 and
chloroform alone. In each case the spots were visual-
ized under ultraviolet light (UV), exposed to iodine va-
pors and sprayed with vanillin sulfuric acid and ferric
chloride solution.
Enzyme inhibition studies (In vitro enzyme inhibition assays)
Protease
Protease assay of crude venom was performed accord-
ing to the method of Greenberg [29]. The reaction mix-
ture composed of 0.5% casein, 1.0 mL of Tris–HCl
buffer (pH 8.0), 0.5 mL of 0.25% crude venom and the
reaction mixture incubated for four hours at 37°C. At
the end of four hours, the reaction was stopped by add-
ing trichloroacetic acid (TCA) and filtered. The filtrate
(1.0 mL) was used for protein estimation by the method
of Lowry et al. [26] using L-tyrosine as a standard. In
the above investigation, one unit of enzyme activity was
defined as the amount that yielded 0.02 μmole of tyro-
sine/hour under experimental conditions described. For
the inhibition studies, venom was preincubated with
the extracts for 30 minutes at 37°C.
Table 1 Weight of the extracts
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5′ Nucleotidase was assayed by the method of Rowe
et al. [30]. The substrate solution contained 1 mL of
Tris–HCl buffer (pH 8.0), 0.1 mL of 0.1 M magnesium
chloride and 0.8 mL of 0.15% 5′AMP followed by
0.25 mL of 0.1% crude venom and incubated at 37°C
for 15 minutes. At the end of incubation time, the reac-
tion was quenched by adding TCA and filtered. The fil-
trate was assayed for inorganic phosphate by the
method of Fiske and Subbarow [31] at 625 nm using
potassium dihydrogen phosphate as standard. In this
analysis, one unit of enzyme activity was defined as the
amount that yielded 0.01 μmole of inorganic phos-
phate/minute under the experimental conditions. For
the inhibition studies, venom was preincubated with
the extracts for 30 minutes at 37°C.
Phosphomonoesterase
The phosphomonoesterase activity was determined by the
method of Bessey et al. [32] with slight modifications. The
reaction mixture included 1.0 mL of Tris–HCl buffer
(pH 8.0), 1.0 mL of disodium-p-nitrophenol phosphate,
0.5 mL of 0.25% crude venom and was incubated at 37°C
for three hours. The absorbance was measured at 425 nm.
p-Nitrophenol was used as the standard. One unit ofTable 2 Qualitative phytochemical analysis of the extracts
Tests Petroleum ether Hexane Chloroform
Alkaloids – – –
Terpenoids + – +
Flavonoids – – +
Phytosterols + + +
Proteins – – +
Carbohydrates – – –
Glycosides – – –
Phenols – – +
Resins – – –
Tannins – – –
Saponins – – +
(+) indicates present, (−) indicates absent.enzyme activity was defined as the amount that yielded
0.1 μmole of p-nitrophenol/hour under the experimental
conditions. For inhibition studies, venom was preincu-
bated with the extracts for 30 minutes at 37°C.
Phosphodiesterase
Phosphodiesterase activity was determined by a method
modified from Lo et al. [33]. The assay mixture contained
0.1 mL of venom solution, 0.5 mL of 0.0025 M Na-p-
nitrophenyl phosphate, 0.3 mL of 0.01 M MgSO4 and
0.5 mL of 0.17 M Tris–HCl (pH 8.0). The absorbance was
measured at 400 nm. Phosphodiesterase activity was
expressed in nanomoles of product released/minute. Molar
extinction coefficient at 400 nm was 8100 Cm−1 M−1 [34].
For the inhibition studies, the venom was preincubated
with the extracts for 30 minutes at 37°C.
L-amino acid oxidase
The L-amino acid oxidase activity was carried out accord-
ing to Li et al. [35]. Reaction mixture consisted of 1.0 mL
of L-leucine, 2.0 mL of Tris–HCl buffer (pH 8.0), 0.25 mL
of 0.1% dianisidine hydrochloride, 0.15 mL of 0.1% horse-
radish peroxidase and 0.04 mL of 0.5% crude venom solu-
tion. It was allowed to stand for ten minutes at room
temperature and then the absorbance was measured at
415 nm. One unit (U) was defined as the amount of en-
zyme that catalyzed the formation of 1 μmol H2O2 per mi-
nute. For the inhibition studies, venom was preincubated
with extracts for 30 minutes at 37°C.
Acetylcholinesterase
Acetylcholine esterase activity was assayed following
Ellman et al. method [36]. The reaction mixture com-
prised 3.0 mL of the phosphate buffer (pH 8.0), 10 μL
of DTNB (10 mmole/L) and 20 μL of acetylethiocholine
iodide (158.5 mmol/L). A total of 50 μL of 0.1% crude
venom and 3 mL of buffer solution was incubated atEthylacetate Methanol Water Ethanol
– + – –
– – – –
+ + – +
+ + + –
+ + – –
– – – –
– – – –
– – + –
– – – –
– – + –
– + + +
1           2            3         4           5            6            7
Figure 1 Thin layer chromatography of the extracts visualized
under ultraviolet light. Lane 1: petroleum ether extract, lane 2:
hexane extract, lane 3: chloroform extract, lane 4: ethyl acetate
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Figure 2 In vitro inhibition studies of Azima tetracantha plant
extracts against the phosphodiesterase enzyme of (A) Vipera russelli
and (B) Bungarus caeruleus venom expressed as percent inhibition.
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DTNB (a strong oxidizing agent) and 20 μL of substrate
acetylethiocholine iodide were added in order to reach
a final concentration of 1 mmole/L. The increase in ab-
sorbance at 412 nm was measured on a double beam
spectrophotometer against control mixture prepared at
the same time. However, in the latter case, 50 μL of en-
zyme was replaced with 50 μL of buffer solution. For
the inhibition studies, venom was preincubated with
extracts for 30 minutes at 37°C.
Hyaluronidase
Hyaluronidase assay of crude venom was determined tur-
bidometrically by the method of Pukrittayakamee et al.
[37]. The assay mixture contained buffer Tris–HCl
(pH 8.0), 50 μg of hyaluronic acid (0.5 mg/mL in buffer)
and enzymes in a final volume of 1.0 mL. The mixture
was incubated for 15 minutes at 37°C and the reaction
was quenched by the addition of 2 mL of 2.5% (w/v) cetyl-
trimethylammonium bromide in 2% NaOH (w/v). The ab-
sorbance was read at 400 nm (within ten minutes) against
a control solution containing 1 mL of the same buffer
and 2 mL of 2.5% (w/v) cetyltrimethylammonium
bromide in 2% NaOH (w/v). Turbidity reducing activity
was expressed as a percentage of the remaining hyalur-
onic acid, taking the absorbance of a tube in which no
enzyme was added as 100%. One unit was defined as
the amount of enzyme that provoked 50% turbidity re-
duction. Specific activity was defined as turbidity redu-
cing units per milligram of enzyme. For the inhibition
studies, venom was preincubated with extracts for
30 minutes at 37°C.
Phospholipase A2
Phospholipase A2 assay was determined according to the
acidimetric method of Tan and Tan [38] with slight modi-
fication. Briefly, a lecithin suspension was prepared with
1% lecithin, 18 mM calcium chloride, and 8.1 mM sodium
deoxycholate in equal proportions. The pH of the suspen-
sion was adjusted to 8.0 with 1 M sodium hydroxide, and
stirred for ten minutes to ensure homogenous mixing. An
amount of 0.1 mL of venom solution/fraction was added
to 15 mL of egg yolk suspension to initiate the hydrolysis.
The initial decrease in pH was measured. A decrease of 1
pH unit corresponded to 133 μmoles of fatty acid release.
Enzyme activity was expressed as μmoles of fatty acid re-
leased/minute [34]. For the inhibition studies, venom was
preincubated with extracts for 30 minutes at 37°C.
Results and discussion
The extracts were dried using a vacuum evaporator and
weight was expressed in terms of dry weight and tabulated
in Table 1. The qualitative phytochemical analysis of plant
extracts showed significant presence of the metabolites(Table 2). The analysis showed that alkaloids were present
only in methanolic extracts which were devoid of carbohy-
drates, glycosides and resins. The study by Maruthi et al.
[39] showed similar results except for the presence of carbo-
hydrates. Another study by Muthuswamy et al. [40] reported
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to the time and season in which leaves were collected.
The thin layer chromatography profiling of all seven ex-
tracts provides an insight of the number of phytochemi-
cals present in the extracts. Each extract was separated in
a different solvent system according to their polarity and
in different ratios of solvent systems. The components in
petroleum ether, chloroform and ethylacetate extracts
were well separated in petroleum ether and ethylacetate
solvent system in the ratio 9:1 and 8:2 respectively. The
spots in methanolic extract were well separated in chloro-
form alone and aqueous extract in methanol, water and
formic acid in the ratio 18:9:1. Spots were well defined in
ethanolic and hexane extracts with the hexane and ethyla-
cetate solvent system in the ratio 9:1. The visualization of
spots was better under UV compared to rest of the agents
used. The Figure 1 shows the results under UV light.
Enzymatic and inhibition studies revealed that the ethyla-
cetate extract of the plant was able to inhibit phospho-
diesterase (Figure 2), phosphomonoesterase (Figure 3),
acetylcholinesterase (Figure 4), 5′ nucleotidase (Figure 5),
phospholipase A2 (Figure 6) and hyaluronidase (Figure 7)
enzymes present in the venom which renders it as an active
extract. The extract is able to inhibit these toxic enzymes in
both venoms at 100 μg/mL concentration. The protease andFigure 4 In vitro inhibition studies of Azima tetracantha plant
extracts against the acetylcholinesterase enzyme of (A) Vipera
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Figure 3 In vitro inhibition studies of Azima tetracantha plant extracts
against the phosphomonoesterase enzyme of (A) Vipera russelli and
(B) Bungarus caeruleus venom expressed as percent inhibition.L-amino acid oxidase enzymes were not inhibited by any of
the extracts in both venoms. Phospholipase A2 and hyal-
uronidase of Vipera russelli and Bungarus caeruleus was
not inhibited by any of the extracts respectively. The
chloroform extract also shows promising results but the
acetylcholinesterase was well inhibited in ethyl acetate ex-
tract, as it is one of the most toxic enzymes present in
venoms of these snakes.
A previous work by Dhananjaya et al. [41] has reported
the inhibition of enzymes present in Russell’s viper venom
by Mangifera indica stem bark extract at lower concentra-
tions. The studies by Gopi et al. [42] have also reported the
inhibition of toxic enzymes present in the Naja naja venom
by Andrographis paniculata active methanolic extract. The
present study was performed using a concentration of
100 μg/mL, but the enzyme inhibiting concentration would
be as lower as 10 to 500 μL of the diluted extract. Therefore,
the actual concentration required to inhibit the enzymes
completely should be studied with different concentrations
of the active extract.
Conclusion
In India, snakebite is a major health problem that leads to
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Figure 7 In vitro inhibition studies of Azima tetracantha plant
extracts against the hyaluronidase enzyme of Vipera russelli
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Figure 5 In vitro inhibition studies of Azima tetracantha plant
extracts against the 5′ nucleotidase enzyme of (A) Vipera russelli
and (B) Bungarus caeruleus venom expressed as percent inhibition.
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the country and a large number of deaths occur due to en-
venomation by these snakes. Snake antivenom remains the
only specific treatment against envenomation by snakes. It
is usually derived from horse sera, therefore it contains ani-
mal immunoglobulins (that frequently cause complement-
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Figure 6 In vitro inhibition studies of Azima tetracantha plant
extracts against phospholipase A2 enzyme of Bungarus caeruleus
venom expressed as percent inhibition.serum sickness and, occasionally, anaphylactic shock). Al-
though the use of plants against snakebites has been long
observed, more scientific attention has been given since to it
in the recent 20 years [43]. Several Indian medicinal plants
are employed by folk medicine for the treatment of snake-
bites [6]. In the current study, we examined the antivenom
potential of A. tetracantha Lam. plant extracts. The inhib-
ition potential of plant extracts in relation to snake toxic en-
zymes was assayed. The studies were carried out by
incubating the venom with plant extracts prior to analysis.
The results showed that plant extracts were capable of
inhibiting such enzymes. The ethylacetate extract, par-
ticularly, showed promising inhibition activity against
phosphomonoesterase, phosphodiesterase, acetylcholin-
esterase, phospholipase A2, 5′ nucleotidase and hyal-
uronidase enzymes, whereas the protease L-amino acid
oxidase could not be inhibited. The inhibitory activities
of plant extracts against snake venoms should be fur-
ther confirmed by in vivo studies using animal models
and by pharmacological analysis in vitro including
neutralization of fibrinogenolytic activity, neutralization
of procoagulant activity and neutralization of hemolytic
activity. The authors believe that plant extracts could
lead to the development of new drugs against the
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